Obesity or Overweight GLP-1 medications are particularly beneficial for individuals who are overweight or obese, as they can help promote weight loss in addition to improving blood sugar control
These medications are prepared by specialized pharmacists to meet specific patient needs
Notably, the simultaneous use of both pharmacological classes provided a significantly greater benefit in outcomes such as mortality, hospitalizations, heart failure, and CKD ( Building on the findings of the aforementioned trials, several meta-analyses have been conducted since 2019 to evaluate the safety and efficacy of combining GLP-1 RAs and SGLT-2 inhibitors
Association between obesity and suicide in woman, but not in man: a population-based study of young adults
Consider combining them: Try circuit training that mixes strength moves with short bursts of cardio
Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review